Key result
Chemotherapy, radiotherapy, and hematopoietic stem cell transplantation are the main known causes of arterial stiffness increase in hematologic malignancies.
Why the study?
What are the mechanisms and causes of increased arterial stiffness in patients with hematologic malignancies?
What are the mechanisms and causes of increased arterial stiffness in patients with hematologic malignancies?
Hematologic cancer treatments increase arterial stiffness through multiple mechanisms, highlighting the need for cardiovascular health screening and risk assessment in cancer survivors.
No takes yet. Share an insight, caveat, or question.
Supports CV screening in hematologic malignancy survivors; leaves open prospective trials on stiffness mitigation.
Mozoş et al. (2017) conducted a review in Hematologic malignancies and arterial stiffness. Hematologic malignancies and associated treatments (chemotherapy, radiotherapy, stem cell transplantation) was evaluated on Arterial stiffness. Chemotherapy, radiotherapy, and hematopoietic stem cell transplantation are the main known causes of arterial stiffness increase in hematologic malignancies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: